Literature DB >> 18361527

Structure and dynamics of Cu(I) binding in copper chaperones Atox1 and CopZ: a computer simulation study.

Agustina Rodriguez-Granillo1, Pernilla Wittung-Stafshede.   

Abstract

Copper chaperones deliver reduced copper (i.e., Cu(I)) to metal-binding domains of P-type ATPases in the cytoplasm of a range of organisms. Both chaperones and target domains have a ferredoxin-like fold and metal-binding motifs involving two Cys residues. Here, we investigated the Cu-binding geometry and structural dynamics of two homologous Cu(I) chaperones, Homo sapiens Atox1 and Bacillus subtilis CopZ, using a combination of quantum mechanical-molecular mechanics (QM-MM) and classical molecular dynamics (MD) methods. Our QM-MM optimized geometries for the holo- proteins suggested that Cu(I) in Atox1 favors a linear Cys(S)-Cu-Cys(S) arrangement but that this angle is close to 150 degrees in CopZ. Classical MD simulations suggest that both Atox1 and CopZ apo- forms have an increased conformational flexibility as compared to the respective holo- forms. This difference is most pronounced in CopZ and correlates with a lower in vitro thermal stability. Both average fluctuation (i.e., rmsd) and radius of gyration data demonstrate that the effects of Cu(I) coordination extend throughout the proteins. Distinct deviations between the two homologues were found in protein-solvent interactions, entropy of Cu(I) binding, and apo-protein Cys-Cys distance distributions. Our in silico results provide new insights into copper chaperone behavior with direct implications for copper transport mechanisms in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18361527     DOI: 10.1021/jp711787x

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  8 in total

1.  The structural flexibility of the human copper chaperone Atox1: Insights from combined pulsed EPR studies and computations.

Authors:  Ariel R Levy; Meital Turgeman; Lada Gevorkyan-Aiapetov; Sharon Ruthstein
Journal:  Protein Sci       Date:  2017-05-31       Impact factor: 6.725

Review 2.  An expanding range of functions for the copper chaperone/antioxidant protein Atox1.

Authors:  Yuta Hatori; Svetlana Lutsenko
Journal:  Antioxid Redox Signal       Date:  2013-02-06       Impact factor: 8.401

3.  Conserved residues modulate copper release in human copper chaperone Atox1.

Authors:  Faiza Hussain; John S Olson; Pernilla Wittung-Stafshede
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

4.  Interactions between copper-binding sites determine the redox status and conformation of the regulatory N-terminal domain of ATP7B.

Authors:  Erik S LeShane; Ujwal Shinde; Joel M Walker; Amanda N Barry; Ninian J Blackburn; Martina Ralle; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

5.  Investigating the role of zinc and copper binding motifs of trafficking sites in the cyanobacterium Synechocystis PCC 6803.

Authors:  Adriana Badarau; Arnaud Baslé; Susan J Firbank; Christopher Dennison
Journal:  Biochemistry       Date:  2013-09-19       Impact factor: 3.162

6.  Copper-zinc superoxide dismutase (Sod1) activation terminates interaction between its copper chaperone (Ccs) and the cytosolic metal-binding domain of the copper importer Ctr1.

Authors:  Amélie Skopp; Stefanie D Boyd; Morgan S Ullrich; Li Liu; Duane D Winkler
Journal:  Biometals       Date:  2019-07-10       Impact factor: 2.949

7.  In vitro thermodynamic dissection of human copper transfer from chaperone to target protein.

Authors:  Moritz S Niemiec; Christoph F Weise; Pernilla Wittung-Stafshede
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

8.  Cu(I) Controls Conformational States in Human Atox1 Metallochaperone: An EPR and Multiscale Simulation Study.

Authors:  Ortal Perkal; Zena Qasem; Meital Turgeman; Renana Schwartz; Lada Gevorkyan-Airapetov; Matic Pavlin; Alessandra Magistrato; Dan Thomas Major; Sharon Ruthstein
Journal:  J Phys Chem B       Date:  2020-05-22       Impact factor: 2.991

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.